BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14565870)

  • 1. Expression of the proto-oncogene Axl in renal cell carcinoma.
    Chung BI; Malkowicz SB; Nguyen TB; Libertino JA; McGarvey TW
    DNA Cell Biol; 2003 Aug; 22(8):533-40. PubMed ID: 14565870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival.
    Gustafsson A; Martuszewska D; Johansson M; Ekman C; Hafizi S; Ljungberg B; Dahlbäck B
    Clin Cancer Res; 2009 Jul; 15(14):4742-9. PubMed ID: 19567592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma.
    Yu H; Liu R; Ma B; Li X; Yen HY; Zhou Y; Krasnoperov V; Xia Z; Zhang X; Bove AM; Buscarini M; Parekh D; Gill IS; Liao Q; Tretiakova M; Quinn D; Zhao J; Gill PS
    Br J Cancer; 2015 Aug; 113(4):616-25. PubMed ID: 26180925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA HOTAIR regulates HIF-1α/AXL signaling through inhibition of miR-217 in renal cell carcinoma.
    Hong Q; Li O; Zheng W; Xiao WZ; Zhang L; Wu D; Cai GY; He JC; Chen XM
    Cell Death Dis; 2017 May; 8(5):e2772. PubMed ID: 28492542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels.
    Fritz HK; Gustafsson A; Ljungberg B; Ceder Y; Axelson H; Dahlbäck B
    PLoS One; 2015; 10(8):e0135991. PubMed ID: 26287733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axl-gas6 interaction counteracts E1A-mediated cell growth suppression and proapoptotic activity.
    Lee WP; Liao Y; Robinson D; Kung HJ; Liu ET; Hung MC
    Mol Cell Biol; 1999 Dec; 19(12):8075-82. PubMed ID: 10567533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AXL targeting by a specific small molecule or monoclonal antibody inhibits renal cell carcinoma progression in an orthotopic mice model.
    Chen TJ; Mydel P; Benedyk-Machaczka M; Kamińska M; Kalucka U; Blø M; Furriol J; Gausdal G; Lorens J; Osman T; Marti HP
    Physiol Rep; 2021 Dec; 9(23):e15140. PubMed ID: 34877810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases Axl and Sky in human uterine endometrial cancers.
    Sun WS; Fujimoto J; Tamaya T
    Ann Oncol; 2003 Jun; 14(6):898-906. PubMed ID: 12796028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profile of receptor-type protein tyrosine kinase genes in the human thyroid.
    Tanaka K; Nagayama Y; Nakano T; Takamura N; Namba H; Fukada S; Kuma K; Yamashita S; Niwa M
    Endocrinology; 1998 Mar; 139(3):852-8. PubMed ID: 9492013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axl receptor tyrosine kinase expression in human lung cancer cell lines correlates with cellular adhesion.
    Wimmel A; Glitz D; Kraus A; Roeder J; Schuermann M
    Eur J Cancer; 2001 Nov; 37(17):2264-74. PubMed ID: 11677117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the TR4 nuclear receptor-mediated lncTASR/AXL signaling with tretinoin increases the sunitinib sensitivity to better suppress the RCC progression.
    Shi H; Sun Y; He M; Yang X; Hamada M; Fukunaga T; Zhang X; Chang C
    Oncogene; 2020 Jan; 39(3):530-545. PubMed ID: 31501521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human chondrocyte expression of growth-arrest-specific gene 6 and the tyrosine kinase receptor axl: potential role in autocrine signaling in cartilage.
    Loeser RF; Varnum BC; Carlson CS; Goldring MB; Liu ET; Sadiev S; Kute TE; Wallin R
    Arthritis Rheum; 1997 Aug; 40(8):1455-65. PubMed ID: 9259426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma.
    Gustafsson A; Boström AK; Ljungberg B; Axelson H; Dahlbäck B
    PLoS One; 2009 Oct; 4(10):e7575. PubMed ID: 19888345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival.
    van Ginkel PR; Gee RL; Shearer RL; Subramanian L; Walker TM; Albert DM; Meisner LF; Varnum BC; Polans AS
    Cancer Res; 2004 Jan; 64(1):128-34. PubMed ID: 14729616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET.
    Rankin EB; Fuh KC; Castellini L; Viswanathan K; Finger EC; Diep AN; LaGory EL; Kariolis MS; Chan A; Lindgren D; Axelson H; Miao YR; Krieg AJ; Giaccia AJ
    Proc Natl Acad Sci U S A; 2014 Sep; 111(37):13373-8. PubMed ID: 25187556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acidification prevents endothelial cell apoptosis by Axl activation.
    D'Arcangelo D; Gaetano C; Capogrossi MC
    Circ Res; 2002 Oct; 91(7):e4-12. PubMed ID: 12364394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis.
    Neubauer A; Fiebeler A; Graham DK; O'Bryan JP; Schmidt CA; Barckow P; Serke S; Siegert W; Snodgrass HR; Huhn D
    Blood; 1994 Sep; 84(6):1931-41. PubMed ID: 7521695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway.
    O'Donnell K; Harkes IC; Dougherty L; Wicks IP
    Am J Pathol; 1999 Apr; 154(4):1171-80. PubMed ID: 10233855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors.
    Mahadevan D; Cooke L; Riley C; Swart R; Simons B; Della Croce K; Wisner L; Iorio M; Shakalya K; Garewal H; Nagle R; Bearss D
    Oncogene; 2007 Jun; 26(27):3909-19. PubMed ID: 17325667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the Axl tyrosine kinase receptor in cutaneous SCC-derived cell lines and tumours.
    Green J; Ikram M; Vyas J; Patel N; Proby CM; Ghali L; Leigh IM; O'Toole EA; Storey A
    Br J Cancer; 2006 May; 94(10):1446-51. PubMed ID: 16641895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.